Sagimet Biosciences (SGMT) Net Income

Annual Net Income

-$27.88 M
+$2.62 M+8.60%

December 31, 2023


Summary


Performance

SGMT Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSGMTprofitabilitymetrics:

Quarterly Net Income

-$14.62 M
-$6.50 M-80.08%

September 30, 2024


Summary


Performance

SGMT Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSGMTprofitabilitymetrics:

TTM Net Income

-$37.52 M
-$8.27 M-28.26%

September 30, 2024


Summary


Performance

SGMT TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSGMTprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SGMT Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.6%-79.3%-34.6%
3 y3 years-145.2%-121.9%-32.3%
5 y5 years-95.5%-121.9%-32.3%

SGMT Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-14.1%+8.6%-163.5%at low-576.2%at low
5 y5-year-145.2%+8.6%-267.0%at low-841.9%at low
alltimeall time-145.2%+8.6%-267.0%at low-841.9%at low

Sagimet Biosciences Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$14.62 M(+80.1%)
-$37.52 M(+28.3%)
Jun 2024
-
-$8.12 M(+22.5%)
-$29.25 M(+4.8%)
Mar 2024
-
-$6.63 M(-18.7%)
-$27.92 M(+0.2%)
Dec 2023
-$27.88 M(-8.6%)
-$8.15 M(+28.3%)
-$27.88 M(+3.6%)
Sep 2023
-
-$6.35 M(-6.4%)
-$26.92 M(-4.0%)
Jun 2023
-
-$6.79 M(+3.0%)
-$28.03 M(-1.1%)
Mar 2023
-
-$6.59 M(-8.5%)
-$28.35 M(-7.0%)
Dec 2022
-$30.50 M
-$7.20 M(-3.6%)
-$30.50 M(+30.9%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$7.47 M(+5.1%)
-$23.30 M(+47.1%)
Jun 2022
-
-$7.10 M(-18.7%)
-$15.84 M(+81.3%)
Mar 2022
-
-$8.73 M(+57.4%)
-$8.73 M(+57.4%)
Dec 2021
-$24.44 M(+115.0%)
-
-
Mar 2021
-
-$5.55 M(+39.3%)
-$5.55 M(+39.3%)
Dec 2020
-$11.37 M(-20.3%)
-
-
Mar 2020
-
-$3.98 M
-$3.98 M
Dec 2019
-$14.26 M
-
-

FAQ

  • What is Sagimet Biosciences annual net profit?
  • What is the all time high annual net income for Sagimet Biosciences?
  • What is Sagimet Biosciences annual net income year-on-year change?
  • What is Sagimet Biosciences quarterly net profit?
  • What is the all time high quarterly net income for Sagimet Biosciences?
  • What is Sagimet Biosciences quarterly net income year-on-year change?
  • What is Sagimet Biosciences TTM net profit?
  • What is the all time high TTM net income for Sagimet Biosciences?
  • What is Sagimet Biosciences TTM net income year-on-year change?

What is Sagimet Biosciences annual net profit?

The current annual net income of SGMT is -$27.88 M

What is the all time high annual net income for Sagimet Biosciences?

Sagimet Biosciences all-time high annual net profit is -$11.37 M

What is Sagimet Biosciences annual net income year-on-year change?

Over the past year, SGMT annual net profit has changed by +$2.62 M (+8.60%)

What is Sagimet Biosciences quarterly net profit?

The current quarterly net income of SGMT is -$14.62 M

What is the all time high quarterly net income for Sagimet Biosciences?

Sagimet Biosciences all-time high quarterly net profit is -$3.98 M

What is Sagimet Biosciences quarterly net income year-on-year change?

Over the past year, SGMT quarterly net profit has changed by -$6.47 M (-79.35%)

What is Sagimet Biosciences TTM net profit?

The current TTM net income of SGMT is -$37.52 M

What is the all time high TTM net income for Sagimet Biosciences?

Sagimet Biosciences all-time high TTM net profit is -$3.98 M

What is Sagimet Biosciences TTM net income year-on-year change?

Over the past year, SGMT TTM net profit has changed by -$9.64 M (-34.59%)